EXpanded Combination of Evolocumab Plus Empagliflozin on Diabetes: EXCEED-BHS3 Trial

Clinical trial NCT03932721 · COMPLETED

Trial details

NCT number: NCT03932721
Sponsor: University of Campinas, Brazil
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Dyslipidemia Associated With Type II Diabetes Mellitus Diabetes Mellitus, Type 2 Hypertension Arterial

Start date: 2018-10-01
Primary completion: 2021-06-30
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.